Secukinumab Injection

DRUG3 trials

Sponsors

National Medical Research Center for Children's Health, Russian Federation, Jinnah Postgraduate Medical Centre, Duke University

Conditions

Congenital IchthyosisMetastatic MelanomaPlaque Psoriasis

Phase 1

IL-17 Blockade to Decrease irAEs (REPLAY)

RecruitingNCT07237594

Duke UniversityMetastatic Melanoma

Start: 2026-03-12End: 2030-06-30Target: 4Updated: 2026-06-04

Phase 4

Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children

National Medical Research Center for Children's Health, Russian FederationCongenital Ichthyosis

Start: 2021-03-01End: 2023-06-01Target: 50Updated: 2021-08-09

Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.

CompletedNCT05891964

Jinnah Postgraduate Medical CentrePlaque Psoriasis

Start: 2021-07-05End: 2022-07-10Updated: 2023-06-07